デフォルト表紙
市場調査レポート
商品コード
1762327

プラセンタ市場、規模、シェア、動向、産業分析レポート:タイプ別、用途別、地域別、2025年~2034年の市場予測

Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2025-2034


出版日
ページ情報
英文 113 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
プラセンタ市場、規模、シェア、動向、産業分析レポート:タイプ別、用途別、地域別、2025年~2034年の市場予測
出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 113 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のプラセンタ市場規模は2034年までに14億487万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

プラセンタ組織と抽出物は、子宮の健康を増進し、胚の着床率を改善し、全体的な生殖能力をサポートするために生殖医療で利用されています。体外受精(IVF)のような生殖補助医療(ART)を受けているカップルは、妊娠の可能性を高めるためにプラセンタベースの治療をますます利用するようになっています。臨床研究では、プラセンタ抽出物に含まれる生物活性化合物が子宮内膜の受容性を改善し、胚の着床をより成功させることが示唆されています。ライフスタイルの変化、ストレス、妊娠の遅れなどの要因により不妊率が上昇し続ける中、プラセンタ由来の不妊治療などの革新的な解決策へのニーズは高まることが予想されます。このように、不妊治療におけるプラセンタの利用拡大は、プラセンタ市場の成長に寄与しています。

皮膚科学、毛髪学、生殖医療におけるプラセンタの応用に対する認識の高まりは、引き続き需要を煽っています。特に女性や特定の民族の間で円形脱毛症が流行しつつあり、プラセンタの再生特性を利用した高度な治療へのニーズが高まっています。現在進行中の科学的研究により、プラセンタベースの製品の有効性が強化され、医療や化粧品分野での利用が広がっています。

プラセンタ市場は、医療や化粧品業界全体でプラセンタ由来製品の需要が高まるにつれ、急速に拡大しています。アンチエイジング・スキンケアからヘアケア、不妊治療に至るまで、プラセンタエキスの利用が技術革新と投資の原動力となっています。自然で科学的な裏付けのあるソリューションへの嗜好の高まりが、プラセンタ市場の需要に拍車をかけています。企業は継続的に新しい製剤を開発し、市場拡大を牽引しています。継続的な進歩により、プラセンタ市場は美容、健康、ウェルネス産業における重要なプレーヤーであり続けています。

プラセンタ市場レポートハイライト

タイプ別では、豚プラセンタの汎用性と入手可能性により、豚セグメントが2024年のプラセンタ市場シェアを独占しました。豚プラセンタは、コラーゲン、タンパク質、生理活性ペプチドを豊富に含むことから、市場において貴重な資源として浮上しています。

用途別では、医薬品分野が予測期間中に最も高いCAGRを記録すると予測されています。医薬品分野では、プラセンタ抽出物はその治療特性について研究されてきました。成長因子、サイトカイン、細胞外小胞のような生物活性分子の豊富な組成は、プラセンタ抽出物を治療用途の有望な候補としています。

北米は、プラセンタベースの化粧品、健康補助食品、医薬品の需要増加などの要因により、2024年のプラセンタ市場の世界売上高シェアを独占しました。

アジア太平洋の市場は、筋ジストロフィーのような希少疾患の有病率の上昇とプラセンタベースのサプリメント需要の増加により、今後数年間で最も高いCAGRを記録すると予想されています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

  • プラセンタ- 業界スナップショット
  • バリューチェーン分析
  • プラセンタ市場力学
    • 促進要因と機会
      • 再生医療と創傷治癒における応用の拡大
      • プラセンタ由来バイオ医薬品のイノベーションの成長
    • 抑制要因と課題
      • プラセンタ由来製品の開発コストの高さ
  • ポーターの5つの力
    • 代替品の脅威:(中~高)
    • 新規参入業者の脅威:中~高
    • 買い手の交渉力:中程度から高い
    • 供給企業の交渉力:中程度
    • 競争企業間の敵対関係:高
  • PESTLE分析

第5章 プラセンタ市場の評価:タイプ別

  • イントロダクション
  • その他

第6章 プラセンタ市場の評価:用途別

  • イントロダクション
  • 医薬品
  • 化粧品
  • サプリメント
  • その他

第7章 プラセンタ市場の評価:地域別

  • イントロダクション
  • 北米プラセンタ市場
    • 国別
    • タイプ別
    • 米国のプラセンタ市場
    • カナダプラセンタ市場
  • 欧州のプラセンタ市場
    • 国別
    • タイプ別
    • 用途別
    • 英国のプラセンタ市場
    • フランスのプラセンタ市場
    • ドイツのプラセンタ市場
    • イタリアプラセンタ市場
    • スペインプラセンタ市場
    • オランダのプラセンタ市場
    • ロシアのプラセンタ市場
    • その他欧州のプラセンタ市場
  • アジア太平洋地域のプラセンタ市場
    • 国別
    • タイプ別
    • 用途別
    • 中国のプラセンタ市場
    • 日本プラセンタ市場
    • 韓国のプラセンタ市場
    • インドのプラセンタ市場
    • インドネシアのプラセンタ市場
    • マレーシアのプラセンタ市場
    • その他アジア太平洋地域のプラセンタ市場
  • ラテンアメリカのプラセンタ市場
    • 国別
    • タイプ別
    • 用途別
    • ブラジルのプラセンタ市場
    • メキシコプラセンタ市場
    • アルゼンチンプラセンタ市場
    • その他ラテンアメリカのプラセンタ市場
  • 中東およびアフリカのプラセンタ市場
    • 国別
    • タイプ別
    • 用途別
    • UAEプラセンタ市場
    • イスラエルのプラセンタ市場
    • サウジアラビアのプラセンタ市場
    • 南アフリカのプラセンタ市場
    • その他中東とアフリカのプラセンタ市場

第8章 競合情勢

  • 戦略的枠組み
  • 戦略的枠組み
  • ベンダー情勢
  • 最近の開発

第9章 企業プロファイル

  • Japan Natural Laboratories Co., LTD.
  • Japan Bio Products Co. Ltd
  • ALBERT DAVID LIMITED
  • Atlanta Placenta Encapsulation
  • MIMEDX Group, Inc.
  • PURTIER Placenta
  • The Placenta Company
  • Smith+Nephew
  • Mommy made encapsulation
  • Nubloom LLC.
図表

List of Tables

  • Table 1 Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 2 Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 3 Placenta Market Assessment, By Geography, 2021 - 2034 (USD Million)
  • Table 4 North America Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 5 North America Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 6 North America Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 7 US Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 8 US Placenta Market, By Solutions, 2021 - 2034 (USD Million)
  • Table 9 Canada Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 10 Canada Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 11 Europe Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 12 Europe Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 13 Europe Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 14 UK Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 15 UK Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 16 France Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 17 France Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 18 Germany Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 19 Germany Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 20 Italy Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 21 Italy Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 22 Spain Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 23 Spain Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 24 Netherlands Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 25 Netherlands Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 26 Russia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 27 Russia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 28 Rest of Europe Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 29 Rest of Europe Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 30 Asia Pacific Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 31 Asia Pacific Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 32 Asia Pacific Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 33 China Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 34 China Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 35 Japan Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 36 Japan Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 37 South Korea Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 38 South Korea Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 39 India Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 40 India Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 41 Indonesia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 42 Indonesia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 43 Malaysia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 44 Malaysia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 45 Rest of Asia Pacific Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 46 Rest of Asia Pacific Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 47 Latin America Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 48 Latin America Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 49 Latin America Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 50 Brazil Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 51 Brazil Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 52 Mexico Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 53 Mexico Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 54 Argentina Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 55 Argentina Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 56 Rest of Latin America Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 57 Rest of Latin America Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 58 Middle East and Africa Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 59 Middle East and Africa Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 60 Middle East and Africa Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 61 UAE Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 62 UAE Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 63 Israel Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 64 Israel Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 65 Saudi Arabia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 66 Saudi Arabia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 67 South Africa Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 68 South Africa Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 69 Rest of Middle East & Africa Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 70 Rest of Middle East & Africa Placenta Market, By Application, 2021 - 2034 (USD Million)

List of Figures

  • Figure 1. Information Procurement
  • Figure 2. Primary Research Pattern
  • Figure 3. Primary research process
  • Figure 4. Market research approaches - Bottom-Up Approach
  • Figure 5. Market research approaches - Top-Down Approach
  • Figure 6. Market research approaches - Combined Approach
  • Figure 7. Executive Summary
  • Figure 8. Market by Region, 2024 (USD Million)
  • Figure 9. Placenta Market, 2021 - 2034 (USD Million)
  • Figure 10. Value Chain Analysis
  • Figure 11. Porter's Five Forces
  • Figure 12. PESTLE Analysis
  • Figure 13. Market, By Type
  • Figure 14. Placenta Market, By Type, 2024 & 2034 (USD Million)
  • Figure 15. Placenta Market, By Porcine, 2021 - 2034 (USD Million)
  • Figure 16. Placenta Market, By Equine, 2021 - 2034 (USD Million)
  • Figure 17. Placenta Market, By Ovine, 2021 - 2034 (USD Million)
  • Figure 18. Placenta Market, By Others, 2021 - 2034 (USD Million)
  • Figure 19. Market, By Application
  • Figure 20. Placenta Market, By Application, 2024 & 2034 (USD Million)
  • Figure 21. Placenta Market, By Pharmaceuticals, 2021 - 2034 (USD Million)
  • Figure 22. Placenta Market, By Cosmetics, 2021 - 2034 (USD Million)
  • Figure 23. Placenta Market, By Supplements, 2021 - 2034 (USD Million)
  • Figure 24. Placenta Market, By Others, 2021 - 2034 (USD Million)
  • Figure 25. Placenta Market Assessment, By Geography, 2024 & 2034 (USD Million)
目次
Product Code: PM3162

The global placenta market size is expected to reach USD 1,404.87 million by 2034, according to a new study by Polaris Market Research. The report "Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Placental tissues and extracts are utilized in reproductive medicine to enhance uterine health, improve embryo implantation rates, and support overall fertility. Couples undergoing assisted reproductive technologies (ART), such as in-vitro fertilization (IVF), are increasingly turning to placenta-based treatments to enhance their chances of conception. Clinical research suggests that bioactive compounds found in placental extracts improve endometrial receptivity, making embryo implantation more successful. As infertility rates continue to rise due to factors such as lifestyle changes, stress, and delayed pregnancies, the need for innovative solutions such as placenta-derived fertility treatments is expected to grow. Thus, the expanding use of the placenta in fertility treatments is contributing to placenta market growth.

The rising awareness of placenta applications in dermatology, trichology, and reproductive medicine continues to fuel demand. With alopecia areata becoming more prevalent, particularly among women and certain ethnic groups, the need for advanced treatments utilizing the placenta's regenerative properties is growing. Ongoing scientific research is enhancing the effectiveness of placenta-based products, broadening their use across medical and cosmetic fields.

The placenta market is expanding rapidly as demand for placenta-derived products grows across the medical and cosmetic industries. From antiaging skincare to hair care and fertility treatments, the use of placental extracts is driving innovation and investment. The increasing preference for natural and scientifically backed solutions is fueling the placenta market demand. Companies are continuously developing new formulations, driving the market expansion. Ongoing advancements keep the market a significant player in the beauty, health, and wellness industries.

Placenta Market Report Highlights

Based on type, the porcine segment dominated the placenta market share in 2024 due to its versatility and availability of porcine placenta. Porcine (pig) placenta is emerging as a valuable resource in the market, owing to its rich composition of collagen, proteins, and bioactive peptides.

The pharmaceuticals segment, by application, is estimated to register the highest CAGR during the forecast period. In the pharmaceutical segment, placental extracts have been explored for their therapeutic properties. The rich composition of bioactive molecules such as growth factors, cytokines, and extracellular vesicles makes placental extracts promising candidates for therapeutic applications.

North America dominated the global placenta market revenue share in 2024 due to factors such as increasing demand for placenta-based cosmetics, health supplements, and pharmaceutical products.

The market in Asia Pacific is expected to register the highest CAGR in the coming years owing to rising prevalence of rare diseases such as muscular dystrophy and growing demand for placenta-based supplements.

A few global key market players are Japan Natural Laboratories Co., Ltd.; Japan Bio Products Co., Ltd.; Albert David Limited; Atlanta Placenta Encapsulation; MIMEDX Group, Inc.; PURTIER Placenta; The Placenta Company; Smith and Nephew; Mommy Made Encapsulation; and Nubloom LLC.

Polaris Market Research has segmented the placenta market report on the basis of type, application, and region:

By Type Outlook (Revenue, USD Million, 2020-2034)

Porcine

Equine

Ovine

Others

By Application Outlook (Revenue, USD Million, 2020-2034)

Pharmaceuticals

Cosmetics

Supplements

Others

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Russia

Italy

Spain

Netherlands

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

Israel

UAE

Rest of Middle East & Africa

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

Table of Contents

Chapter 1. Introduction

  • 1.1 Report Description
    • 1.1.1 Objective of the Study
    • 1.1.2 Market Scope
    • 1.1.3 Assumptions
  • 1.2 Stakeholders

Chapter 2. Research Methodology

  • 2.1 Research Methodology
  • 2.2 Research Scope and Assumptions
  • 2.3 Information Procurement
    • 2.3.1 Purchased Database
    • 2.3.2 Internal Database
    • 2.3.3 Secondary Sources
    • 2.3.4 Third Party Perspective
    • 2.3.5 Primary Research
  • 2.4 Information Analysis
    • 2.4.1 Data Analysis Models
  • 2.5 Market Formulation and Data Visualization
  • 2.6 Data Validation and Publishing (Secondary Sources)

Chapter 3. Executive Summary

Chapter 4. Market Insights

  • 4.1 Placenta - Industry snapshot
  • 4.2 Placenta Market - Value Chain Analysis
  • 4.3 Placenta Market Dynamics
    • 4.3.1 Drivers and Opportunities
      • 4.3.1.1 Expanding Applications in Regenerative Medicine and Wound Healing
      • 4.3.1.2 Growing Placenta-Derived Biopharmaceutical Innovations
    • 4.3.2 Restraints and Challenges
      • 4.3.2.1 High Cost of Placenta-Based Product Development
  • 4.4 Placenta Market - Porter's Five Forces
    • 4.4.1 Threat of Substitutes: (Moderate to High)
    • 4.4.2 Threat of New Entrants: Moderate to High
    • 4.4.3 Bargaining power of buyers: Moderate to High
    • 4.4.4 Bargaining power of suppliers: Moderate
    • 4.4.5 Competitive Rivalry: High
  • 4.5 Placenta Market - PESTLE Analysis

Chapter 5. Placenta Market Assessment, By Type

  • 5.1 Introduction
  • 5.2 Porcine
  • 5.3 Equine
  • 5.4 Ovine
  • 5.5 Others

Chapter 6. Placenta Market Assessment, By Application

  • 6.1 Introduction
  • 6.2 Pharmaceuticals
  • 6.3 Cosmetics
  • 6.4 Supplements
  • 6.5 Others

Chapter 7. Placenta Market Assessment, By Region

  • 7.1 Introduction
  • 7.2 North America Placenta Market
    • 7.2.1 North America Placenta Market, By Country
    • 7.2.2 North America Placenta Market, By Type
      • 7.2.2.1 North America Placenta Market, By Application
    • 7.2.3 US Placenta Market
      • 7.2.3.1 US Placenta Market, By Type
      • 7.2.3.2 US Placenta Market, By Solutions
    • 7.2.4 Canada Placenta Market
      • 7.2.4.1 Canada Placenta Market, By Type
      • 7.2.4.2 Canada Placenta Market, By Application
  • 7.3 Europe Placenta Market
    • 7.3.1 Europe Placenta Market, By Country
    • 7.3.2 Europe Placenta Market, By Type
    • 7.3.3 Europe Placenta Market, By Application
    • 7.3.4 UK Placenta Market
      • 7.3.4.1 UK Placenta Market, By Type
      • 7.3.4.2 UK Placenta Market, By Application
    • 7.3.5 France Placenta Market
      • 7.3.5.1 France Placenta Market, By Type
      • 7.3.5.2 France Placenta Market, By Application
    • 7.3.6 Germany Placenta Market
      • 7.3.6.1 Germany Placenta Market, By Type
      • 7.3.6.2 Germany Placenta Market, By Application
    • 7.3.7 Italy Placenta Market
      • 7.3.7.1 Italy Placenta Market, By Type
      • 7.3.7.2 Italy Placenta Market, By Application
    • 7.3.8 Spain Placenta Market
      • 7.3.8.1 Spain Placenta Market, By Type
      • 7.3.8.2 Spain Placenta Market, By Application
    • 7.3.9 Netherlands Placenta Market
      • 7.3.9.1 Netherlands Placenta Market, By Type
      • 7.3.9.2 Netherlands Placenta Market, By Application
    • 7.3.10 Russia Placenta Market
      • 7.3.10.1 Russia Placenta Market, By Type
      • 7.3.10.2 Russia Placenta Market, By Application
    • 7.3.11 Rest of Europe Placenta Market
      • 7.3.11.1 Rest of Europe Placenta Market, By Type
      • 7.3.11.2 Rest of Europe Placenta Market, By Application
  • 7.4 Asia Pacific Placenta Market
    • 7.4.1 Asia Pacific Placenta Market, By Country
    • 7.4.2 Asia Pacific Placenta Market, By Type
    • 7.4.3 Asia Pacific Placenta Market, By Application
    • 7.4.4 China Placenta Market
      • 7.4.4.1 China Placenta Market, By Type
      • 7.4.4.2 China Placenta Market, By Application
    • 7.4.5 Japan Placenta Market
      • 7.4.5.1 Japan Placenta Market, By Type
      • 7.4.5.2 Japan Placenta Market, By Application
    • 7.4.6 South Korea Placenta Market
      • 7.4.6.1 South Korea Placenta Market, By Type
      • 7.4.6.2 South Korea Placenta Market, By Application
    • 7.4.7 India Placenta Market
      • 7.4.7.1 India Placenta Market, By Type
      • 7.4.7.2 India Placenta Market, By Application
    • 7.4.8 Indonesia Placenta Market
      • 7.4.8.1 Indonesia Placenta Market, By Type
      • 7.4.8.2 Indonesia Placenta Market, By Application
    • 7.4.9 Malaysia Placenta Market
      • 7.4.9.1 Malaysia Placenta Market, By Type
      • 7.4.9.2 Malaysia Placenta Market, By Application
    • 7.4.10 Rest of Asia Pacific Placenta Market
      • 7.4.10.1 Rest of Asia Pacific Placenta Market, By Type
      • 7.4.10.2 Rest of Asia Pacific Placenta Market, By Application
  • 7.5 Latin America Placenta Market
    • 7.5.1 Latin America Placenta Market, By Country
    • 7.5.2 Latin America Placenta Market, By Type
    • 7.5.3 Latin America Placenta Market, By Application
    • 7.5.4 Brazil Placenta Market
      • 7.5.4.1 Brazil Placenta Market, By Type
      • 7.5.4.2 Brazil Placenta Market, By Application
    • 7.5.5 Mexico Placenta Market
      • 7.5.5.1 Mexico Placenta Market, By Type
      • 7.5.5.2 Mexico Placenta Market, By Application
    • 7.5.6 Argentina Placenta Market
      • 7.5.6.1 Argentina Placenta Market, By Type
      • 7.5.6.2 Argentina Placenta Market, By Application
    • 7.5.7 Rest of Latin America Placenta Market
      • 7.5.7.1 Rest of Latin America Placenta Market, By Type
      • 7.5.7.2 Rest of Latin America Placenta Market, By Application
  • 7.6 Middle East and Africa Placenta Market
    • 7.6.1 Middle East and Africa Placenta Market, By Country
    • 7.6.2 Middle East and Africa Placenta Market, By Type
    • 7.6.3 Middle East and Africa Placenta Market, By Application
    • 7.6.4 UAE Placenta Market
      • 7.6.4.1 UAE Placenta Market, By Type
      • 7.6.4.2 UAE Placenta Market, By Application
    • 7.6.5 Israel Placenta Market
      • 7.6.5.1 Israel Placenta Market, By Type
      • 7.6.5.2 Israel Placenta Market, By Application
    • 7.6.6 Saudi Arabia Placenta Market
      • 7.6.6.1 Saudi Arabia Placenta Market, By Type
      • 7.6.6.2 Saudi Arabia Placenta Market, By Application
    • 7.6.7 South Africa Placenta Market
      • 7.6.7.1 South Africa Placenta Market, By Type
      • 7.6.7.2 South Africa Placenta Market, By Application
    • 7.6.8 Rest of Middle East & Africa Placenta Market
      • 7.6.8.1 Rest of Middle East & Africa Placenta Market, By Type
      • 7.6.8.2 Rest of Middle East & Africa Placenta Market, By Application

Chapter 8. Competitive Landscape

  • 8.1 Strategy Framework
  • 8.2 Strategy Framework
  • 8.3 Vendor Landscape
  • 8.4 Recent Development

Chapter 9. Company Profiles

  • 9.1 Japan Natural Laboratories Co., LTD.
    • 9.1.1 Business Overview
    • 9.1.2 Products Benchmarking
  • 9.2 Japan Bio Products Co. Ltd
    • 9.2.1 Business Overview
    • 9.2.2 Products Benchmarking
    • 9.2.3 Recent Developments
  • 9.3 ALBERT DAVID LIMITED
    • 9.3.1 Business Overview
    • 9.3.2 Financial Snapshot
      • 9.3.2.1 Total Income by Region
    • 9.3.3 Products Benchmarking
    • 9.3.4 Recent Developments
  • 9.4 Atlanta Placenta Encapsulation
    • 9.4.1 Business Overview
    • 9.4.2 Products Benchmarking
  • 9.5 MIMEDX Group, Inc.
    • 9.5.1 Business Overview
    • 9.5.2 Financial Snapshot
    • 9.5.3 Products Benchmarking
    • 9.5.4 Recent Developments
  • 9.6 PURTIER Placenta
    • 9.6.1 Business Overview
    • 9.6.2 Products Benchmarking
  • 9.7 The Placenta Company
    • 9.7.1 Business Overview
    • 9.7.2 Products and Services
  • 9.8 Smith+Nephew
    • 9.8.1 Business Overview
    • 9.8.2 Financial Snapshot
      • 9.8.2.1 Net Sales by Market Segment
    • 9.8.3 Products and Services
  • 9.9 Mommy made encapsulation
    • 9.9.1 Business Overview
    • 9.9.2 Products Benchmarking
  • 9.10 Nubloom LLC.
    • 9.10.1 Business Overview
    • 9.10.2 Products Benchmarking